Erratum: Strategies for Engineering Natural Product Biosynthesis in Fungi: (Trends in Biotechnology (2019) 37(4) (416–427), (S0167779918302567), (10.1016/j.tibtech.2018.09.003));Strategies for Engineering Natural Product Biosynthesis in Fungi

Trends in Biotechnology

Volumn 37, Issue 4, 2019, Pages 416-427

  Skellam, Elizabeth ^a  

^a LEIBNIZ UNIVERSITY HANNOVER   (Germany)

Author keywords

biomolecular engineering; biotechnology; combinatorial biosynthesis; drug discovery; fungi; natural products

Indexed keywords

BIOCHEMISTRY; BIOSYNTHESIS; BIOTECHNOLOGY; DRUG PRODUCTS; ENZYMES; FUNGI;

BIOACTIVE COMPOUNDS; BIOMOLECULAR ENGINEERING; BIOSYNTHETIC ENZYMES; BIOSYNTHETIC GENE CLUSTER; COMBINATORIAL BIOSYNTHESIS; DRUG DISCOVERY; HETEROLOGOUS EXPRESSION; NATURAL PRODUCTS;

BIOCHEMICAL ENGINEERING;

ALPHA AMANITIN; ARTEMISININ; ASIROCHLORINE; ASPERCRYPTIN DERIVATIVE; AUROVERTIN B; AUROVERTIN D; BENZOMALVIN A; CERCOSPORIN; CICHORINE; COMPACTIN; CORDYCEPTIN; CYCLOPEPTIDE; CYCLOSPORINE; FELINONE A; FELLUTAMIDE B; FELLUTAMIDE DERIVATIVE; FUMISOQUIN; GIBBERELLIN GA3; MEROTERPENOID; MEVINOLIN; MYCOPHENOLIC ACID; NATURAL PRODUCT; PENICILLIN G; PENTOSTATIN; PLEUROMUTILIN; PSILOCYBINE; RUBRATOXIN A; STROBILURIN A; TRYPACIDIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; BIOLOGICAL PRODUCT;

BIOCATALYSIS; BIOCATALYST; COMBINATORIAL CHEMISTRY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ENGINEERING; FUNGAL GENETICS; FUNGAL GENOME; FUNGAL METABOLISM; GENE CLUSTER; GENE EDITING; GENE INACTIVATION; GENETIC ENGINEERING; HETEROLOGOUS EXPRESSION; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRANSCRIPTION REGULATION; WHOLE GENOME SEQUENCING; BIOSYNTHESIS; FUNGUS; GENETICS; METABOLIC ENGINEERING; METABOLISM; PROCEDURES;

BIOLOGICAL PRODUCTS; BIOSYNTHETIC PATHWAYS; FUNGI; METABOLIC ENGINEERING;

EID: 85054430369     PISSN: 01677799     EISSN: 18793096     Source Type: Journal    
DOI: 10.1016/j.tibtech.2019.03.014     Document Type: Erratum

References (87)

1. Newman, D.J., Cragg, G.M., Natural products as sources of new drugs from 1981 to 2014. J. Nat. Prod. 79 (2016), 629–661.
2. Karwehl, S., Stadler, M., Exploitation of fungal biodiversity for discovery of novel antibiotics. Curr. Top. Microbiol. Immunol. 398 (2017), 303–338.
3. Bills, G.F., Gloer, J.B., Biologically active secondary metabolites from the fungi. Microbiol. Spectr., 4, 2016, 10.1128/microbiolspec.FUNK-0009-2016.
4. Barkal, J., et al. Microbial metabolomics in open microscale platforms. Nat. Commun., 7, 2016 10610.
5. Rodrigues, T., et al. Counting on natural products for drug design. Nat. Chem. 8 (2016), 531–541.
6. Hawksworth, D.L., Lücking, R., Fungal diversity revisited: 2.2 to 3.8 million species. Microbiol. Spectr., 5, 2017, 10.1128/microbiolspec.FUNK-0052-2016.
7. Nordberg, H., et al. The genome portal of the Department of Energy Joint Genome Institute: 2014 updates. Nucleic Acids Res. 42 (2014), D26–D31.
8. Basenko, E.Y., et al. FungiDB: an integrated bioinformatic resource for fungi and oomycetes. J. Fungi, 4, 2018, 39.
9. Van der Lee, T.A.J., Medema, M.H., Computational strategies for genome-based natural product discovery and engineering in fungi. Fungal Genet. Biol. 89 (2016), 29–36.
10. Andersen, M.R., et al. Accurate prediction of secondary metabolite gene clusters in filamentous fungi. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), E99–E107.
11. Wang, X., et al. Genomic and transcriptomic analysis of the endophytic fungus Pestalotiopsis fici reveals its lifestyle and high potential for synthesis of natural products. BMC Genomics, 16, 2015, 28.
12. Asai, T., et al. Structurally diverse chaetophenol productions induced by chemically mediated epigenetic manipulation of fungal gene expression. Org. Lett. 15 (2013), 3346–3349.
13. Mao, X.M., et al. Epigenetic genome mining of an endophytic fungus leads to the pleiotropic biosynthesis of natural products. Angew. Chem. Int. Ed. Engl. 54 (2015), 7592–7596.
14. Albright, J.C., et al. Large-scale metabolomics reveals a complex response of Aspergillus nidulans to epigenetic perturbation. ACS Chem. Biol. 10 (2015), 1535–1541.
15. Henke, M.T., et al. New aspercryptins, lipopeptide natural products revealed by HDAC inhibition in Aspergillus nidulans. ACS Chem. Biol. 11 (2016), 2117–2123.
16. Chiang, Y.M., et al. Development of genetic dereplication strains in Aspergillus nidulans results in the discovery of aspercryptin. Angew. Chem. Int. Ed. Engl. 55 (2016), 1662–1665.
17. Oakley, C.E., et al. Discovery of McrA, a master regulator of Aspergillus secondary metabolism. Mol. Microbiol. 103 (2017), 347–365.
18. Griffiths, S., et al. Regulation of secondary metabolite production in the fungal tomato pathogen Cladosporium fulvum. Fungal Genet. Biol. 84 (2015), 52–61.
19. Sato, M., et al. Collaborative biosynthesis of maleimide- and succinimide-containing natural products by fungal polyketide megasynthases. J. Am. Chem. Soc. 139 (2017), 5317–5320.
20. Baccile, J.A., et al. Plant-like biosynthesis of isoquinoline alkaloids in Aspergillus fumigatus. Nat. Chem. Biol. 12 (2016), 419–424.
21. Xia, Y., et al. Fungal cordyceptin biosynthesis is coupled with the production of the safeguard molecule pentostatin. Cell Chem. Biol. 24 (2017), 1479–1489.
22. Zhang, S., et al. Self-excising Cre/mutant lox marker recycling system for multiple gene integrations and consecutive gene deletions in Aspergillus oryzae. J. Biosci. Bioeng. 123 (2016), 403–411.
23. Yeh, H.H., et al. Resistance gene-guided genome mining: serial promoter exchanges in Aspergillus nidulans reveal the biosynthetic pathway for fellutamide B, a proteasome inhibitor. ACS Chem. Biol. 11 (2016), 2275–2284.
24. Arazoe, T., et al. Tailor-made TALEN system for highly efficient targeted gene replacement in the rice blast fungus. Biotechnol. Bioeng. 112 (2015), 1335–1342.
25. Mizutani, O., et al. Detailed analysis of targeted gene mutations caused by the platinum-fungal TALENs in Aspergillus oryzae RIB40 strain and a ligD disruptant. J. Biosci. Bioeng. 123 (2017), 287–293.
26. Delmas, S., et al. Development of an unmarked gene deletion system for the filamentous fungi Aspergillus niger and Talaromyces versatilis. Appl. Environ. Microbiol. 80 (2014), 3484–3487.
27. Nagano, N., et al. Class of cyclic ribosomal peptide synthetic genes in filamentous fungi. Fungal Genet. Biol. 86 (2016), 58–70.
28. Ye, Y., et al. Unveiling the biosynthetic pathway of the ribosomally synthesized and post-translationally modified peptide ustiloxin B in filamentous fungi. Angew. Chem. Int. Ed. Engl. 55 (2016), 8072–8075.
29. Bai, J., et al. A cascade of redox reactions generates complexity in the biosynthesis of the protein phosphatase-2 inhibitor rubratoxin A. Angew. Chem. Int. Ed. Engl. 56 (2017), 4782–4786.
30. Chankhamjon, P., et al. Biosynthesis of the halogenated mycotoxin aspirochlorine in koji mold involves a cryptic amino acid conversion. Angew. Chem. Int. Ed. Engl. 53 (2014), 13409–13413.
31. Newman, A.G., Townsend, C.A., Molecular characterization of the cercosporin biosynthetic pathway in the fungal plant pathogen Cercospora nicotianae. J. Am. Chem. Soc. 138 (2016), 4219–4228.
32. Shi, T.-Q., et al. CRISPR/Cas9-based genome editing of the filamentous fungi: the state of the art. Appl. Microbiol. Biotechnol. 101 (2017), 7435–7443.
33. Zheng, Y.-M., et al. Development of a versatile and conventional technique for gene disruption in filamentous fungi based on CRISPR–Cas9 technology. Sci. Rep., 7, 2017, 9250.
34. Nielsen, M.L., et al. Genes linked to production of secondary metabolites in Talaromyces atroroseus revealed using CRISPR–Cas9. PLoS One, 12, 2017, e0169712.
35. Weber, J., et al. Functional reconstitution of a fungal natural product gene cluster by advanced genome editing. ACS Synth. Biol. 6 (2016), 62–68.
36. Bailey, A.M., et al. Identification and manipulation of the pleuromutilin gene cluster from Clitopilus passeckerianus for increased rapid antibiotic production. Sci. Rep., 6, 2016 25202.
37. Goethe, O., et al. Antibacterial properties and clinical potential of pleuromutilins. Nat. Prod. Rep., 2018, 10.1039/C8NP00042E Published online July 6, 2018.
38. Alberti, F., et al. Heterologous expression reveals the biosynthesis of the antibiotic pleuromutilin and generates bioactive semi-synthetic derivatives. Nat. Commun., 8, 2017, 1831.
39. Harvey, C.J.B., et al. HEx: a heterologous expression platform for the discovery of fungal natural products. Sci. Adv., 4, 2018, 5459.
40. Clevenger, K.D., et al. A scalable platform to identify fungal secondary metabolites and their gene clusters. Nat. Chem. Biol. 13 (2017), 895–901.
41. Clevenger, K.D., et al. Interrogation of benzomalvin biosynthesis using FAC-MS: discovery of a benzodiazepine synthase activity. Biochemistry 57 (2018), 3237–3243.
42. Gressler, M., et al. A new high-performance heterologous fungal expression system based on regulatory elements from the Aspergillus terreus terrein gene cluster. Front. Microbiol., 6, 2015, 184.
43. Kakule, T.B., et al. Native promoter strategy for high-yielding synthesis and engineering of fungal secondary metabolites. ACS Synth. Biol. 4 (2015), 625–633.
44. Cochrane, R.V.K., et al. Production of new cladosporin analogues by reconstitution of the polyketide synthases responsible for the biosynthesis of this antimalarial agent. Angew. Chem. Int. Ed. Engl. 55 (2016), 664–668.
45. Huitt-Roehl, C.R., et al. Starter unit flexibility for engineered product synthesis by the nonreducing polyketide synthase PksA. ACS Chem. Biol. 10 (2015), 1443–1449.
46. Asai, T., et al. Use of a biosynthetic intermediate to explore the chemical diversity of pseudo-natural fungal polyketides. Nat. Chem. 7 (2015), 737–743.
47. Tang, M.C., et al. Discovery of unclustered fungal indole diterpene biosynthetic pathways through combinatorial pathway reassembly in engineered yeast. J. Am. Chem. Soc. 137 (2015), 13724–13727.
48. Xie, L., et al. Methylglucosylation of aromatic amino and phenolic moieties of drug-like biosynthons by combinatorial biosynthesis. Proc. Natl. Acad. Sci. U. S. A. 115 (2018), E4980–E4989.
49. McLean, K.J., et al. Single-step fermentative production of the cholesterol lowering drug pravastatin via reprogramming of Penicillium chrysogenum. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 2847–2852.
50. Okada, M., et al. Combinatorial biosynthesis of (+)-daurichromenic acid and its halogenated analogue. Org. Lett. 19 (2017), 3183–3186.
51. Menon, B.R.K., et al. RadH: a versatile halogenase for integration into synthetic pathways. Angew. Chem. Int. Ed. Engl. 56 (2017), 11841–11845.
52. Herr, A., Fischer, R., Improvement of Aspergillus nidulans penicillin production by targeting AcvA to peroxisomes. Metab. Eng. 25 (2014), 131–139.
53. Guo, C.J., et al. Spatial regulation of a common precursor from two distinct genes generates metabolite diversity. Chem. Sci., 6, 2015, 5913.
54. Xu, Y., et al. Diversity-oriented combinatorial biosynthesis of benzenediol lactone scaffolds by subunit shuffling of fungal polyketide synthases. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), 12354–12359.
55. Bai, J., et al. Diversity-oriented combinatorial biosynthesis of hybrid polyketide scaffolds from azaphilone and benzenediol lactone biosynthons. Org. Lett. 18 (2016), 1262–1265.
56. Kakule, T.B., et al. Combinatorialization of fungal polyketide synthase–peptide synthetase hybrid proteins. J. Am. Chem. Soc. 136 (2014), 17882–17890.
57. Nielsen, M.N., et al. Linker flexibility facilitates module exchange in fungal hybrid PKS-NRPS engineering. PLoS One, 11, 2016, e0161199.
58. Xu, Y., et al. Thioesterase domains of fungal nonreducing polyketide synthases act as decision gates during combinatorial biosynthesis. J. Am. Chem. Soc. 135 (2013), 10783–10791.
59. Liu, T., et al. Rational domain swaps reveal insights about chain length control by ketosynthase domains in fungal nonreducing polyketide synthases. Org. Lett. 16 (2014), 1676–1679.
60. Van Dijk, J.W.A., et al. Engineering fungal nonribosomal peptide synthetase-like enzymes by heterologous expression and domain swapping. Org. Lett. 18 (2016), 6236–6239.
61. Yu, D., et al. Decoding and reprogramming fungal iterative nonribosomal peptide synthetases. Nat. Commun., 8, 2017 15349.
62. Qin, B., et al. An unusual chimeric diterpene synthase from Emericella variecolor and its functional conversion into a sesterterpene synthase by domain swapping. Angew. Chem. Int. Ed. Engl. 55 (2016), 1658–1661.
63. Newman, A.G., et al. Systematic domain swaps of iterative, nonreducing polyketide synthases provide a mechanistic understanding and rationale for catalytic reprogramming. J. Am. Chem. Soc. 136 (2014), 7348–7362.
64. Baker Dockrey, S.A., et al. Biocatalytic site- and enantioselective oxidative dearomatization of phenols. Nat. Chem. 10 (2017), 119–125.
65. Sib, A., Gulder, T.A.M., Stereoselective total synthesis of bisorbicillinoid natural products by enzymatic oxidative dearomatization/dimerization. Angew. Chem. Int. Ed. Engl. 56 (2017), 12888–12891.
66. Aleku, G.A., et al. A reductive aminase from Aspergillus oryzae. Nat. Chem. 9 (2017), 961–969.
67. Fricke, J., et al. Enzymatic synthesis of psilocybin. Angew. Chem. Int. Ed. Engl. 56 (2017), 12352–12355.
68. Lin, T.S., et al. Biosynthetic pathway of the reduced polyketide product citreoviridin in Aspergillus terreus var. aureus revealed by heterologous expression in Aspergillus nidulans. Org. Lett. 18 (2016), 1366–1369.
69. Nielsen, M.T., et al. Heterologous reconstitution of the intact geodin gene cluster in Aspergillus nidulans through a simple and versatile PCR based approach. PLoS One, 8, 2013, e72871.
70. Hoefgen, S., et al. Facile assembly and fluorescence-based screening method for heterologous expression of biosynthetic pathways in fungi. Metab. Eng. 48 (2018), 44–51.
71. Brandenburger, E., et al. A highly conserved basidiomycete peptide synthetase produces a trimeric hydroxamate siderophore. Appl. Environ. Microbiol., 83, 2017 e01478-17.
72. Matsuda, Y., et al. Complete biosynthetic pathway of anditomin: nature's sophisticated synthetic route to a complex fungal meroterpenoid. J. Am. Chem. Soc. 136 (2014), 15326–15336.
73. Williams, K., et al. Heterologous production of fungal maleidrides reveals the cryptic cyclization involved in their biosynthesis. Angew. Chem. Int. Ed. Engl. 55 (2016), 6784–6788.
74. Lv, J.M., et al. Biosynthesis of helvolic acid and identification of an unusual C-4-demethylation process distinct from sterol biosynthesis. Nat. Commun., 8, 2017, 1644.
75. Liu, C., et al. Reconstitution of biosynthetic machinery for the synthesis of the highly elaborated indole diterpene penitrem. Angew. Chem. Int. Ed. Engl. 54 (2015), 5748–5752.
76. Schor, R., et al. Three previously unrecognized classes of biosynthetic enzymes revealed during the production of xenovulene A. Nat. Commun., 9, 2018, 1963.
77. Kakule, T.B., et al. Biosynthesis of the tetramic acids Sch210971 and Sch210972. Org. Lett. 17 (2015), 2295–2297.
78. Van de Bittner, K.C., et al. Heterologous biosynthesis of nodulisporic acid F. J. Am. Chem. Soc. 140 (2018), 582–585.
79. Paddon, C.J., et al. High-level semi-synthetic production of the potent antimalarial artemisinin. Nature 496 (2013), 528–532.
80. Awan, R.B., et al. Biosynthesis of the antibiotic nonribosomal peptide penicillin in baker's yeast. Nat. Commun., 8, 2017 15202.
81. Zhou, K., et al. Distributing a metabolic pathway among a microbial consortium enhances production of natural products. Nat. Biotechnol. 33 (2015), 377–383.
82. Galanie, S., et al. Complete biosynthesis of opioids in yeast. Science 349 (2015), 1095–1100.
83. Lin, H.C., et al. P450-mediated coupling of indole fragments to forge communesin and unnatural isomers. J. Am. Chem. Soc. 138 (2016), 4002–4005.
84. Fraley, A.E., et al. Function and structure of MalA/MalA′ iterative halogenases for late-stage C–H functionalization of indole alkaloids. J. Am. Chem. Soc. 139 (2017), 12060–12068.
85. Zhang, W., et al. Functional characterization of MpaG′ the O-methyltransferase involved in the biosynthesis of mycophenolic acid. Chembiochem 16 (2015), 565–569.
86. Newmister, S.A., et al. OxaD: a versatile indolic nitrone synthase from the marine-derived fungus Penicillium oxalicum F30. J. Am. Chem. Soc. 138 (2016), 11176–11184.
87. Abood, A., et al. Kinetic characterization of the FAD dependent monooxygenase TropB and investigation of its biotransformation potential. RSC Adv. 5 (2015), 49987–49995.